This indefinite-delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation as a single-award prime vendor for pharmaceutical products and medical supplies. The base IDV has a potential value of $999,999,999 with a period of performance through December 31, 2025.
Task orders provided indicate the contractor will supply a range of pharmaceuticals to DLA customers from its Conshohocken, Pennsylvania facility, including generic and brand name medications, injections, and medical devices. Orders valued from a few dollars to millions are placed on a daily basis for immediate delivery, with no set-aside provisions applied. Products include analgesics, antibiotics, diabetes medications, and other drugs supporting treatment of conditions like cancer and HIV/AIDS.
As the DLA manages the global supply chain for the Department of Defense, this IDV enables streamlined ordering of critical medical commodities and pharmaceuticals for military treatment facilities worldwide. The low dollar value and short delivery timelines of the task orders suggest this vehicle provides flexibility in meeting urgent clinical needs as they arise.
Generated 1/4/24, 10:47 PM